Incidence, death and DALYs of TB, by age and sex in 2021. by Xue Li (285380)

Subjects:

Composition ratio of each types of tuberculosis ASDR in 1990 and 2021. by Xue Li (285380)

Subjects:

Incidence number, ASIR under the age of 20 in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

Composition ratio of each types of tuberculosis ASMR in 1990 and 2021. by Xue Li (285380)

Subjects:

DALYs number, ASDR under the age of 20 in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

Trends in voluntary disclosure report names for Japanese Listed Companies 2008-2023. by Yuichiro Nakai (689312)

“…<p>This figure highlights the significant increase in the number of Integrated Reports and Company Name Reports, as well as the notable decrease in the number of Annual Reports issued by Japanese listed companies from 2008 to 2023.…”

Genomic downregulation of TGF β1 production in monocytes obtained after RZV administration. Panel A. The heatmap shows 16 genes on the y axis whose accessibility significantly chan... by Michael J. Johnson (5818168)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

EM wave propagation model in porous media of goaf. by Qingsong Zhang (3353270)

Subjects:

Signal intensity curves at 0.2 and 0.4 porosity. by Qingsong Zhang (3353270)

Subjects:

Interior diagram of goaf simulation platform. by Qingsong Zhang (3353270)

Subjects:

EM wave transmission in coal-rock media. by Qingsong Zhang (3353270)

Subjects:

Simulation platform experimental data. by Qingsong Zhang (3353270)

Subjects:

Signal intensity and fitting curves at porosity 1. by Qingsong Zhang (3353270)

Subjects:

Numerical simulation data. by Qingsong Zhang (3353270)

Subjects:

Simulation platform for porous media in goaf. by Qingsong Zhang (3353270)

Subjects:

Processed intensity curve of 800 MHz and 900 MHz. by Qingsong Zhang (3353270)

Subjects:

Dielectric constant and conductivity of different coals. by Qingsong Zhang (3353270)

Subjects: